Therapeutics

MEM 1003

Tools

Back to the Top

Overview

Name: MEM 1003
Synonyms: BAY Z 4406
Therapy Type: Small Molecule
Target Type: Other
Condition(s): Alzheimer's Disease, Mild Cognitive Impairment, Vascular Dementia, Bipolar Disorder
U.S. FDA Status: Alzheimer's Disease (Discontinued), Mild Cognitive Impairment (Discontinued), Vascular Dementia (Discontinued), Bipolar Disorder (Discontinued)
Company: Memory Pharmaceuticals Corporation
Approved for: None

Background

MEM 1003  is a dihydropyridine compound related to nimodipine. It is a Ca2 channel antagonist.

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

No Available Comments

References

No Available References

Further Reading

No Available Further Reading